Search Login Register

Lepromatous Leprosy Summary

825 relevant articles (21 outcomes, 82 trials/studies) found for this Disease

Description: A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.

Also Known As: Leprosy, Lepromatous; Cutaneous Leprosies; Cutaneous Leprosy; Lepromatous Leprosies; Leprosies, Cutaneous Show All >>

Key Drugs and Agents for Lepromatous Leprosy

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Dapsone : 3 outcomes 11 studies in 72 results : FDA 3
  2. Rifampin (Rifampicin) : 2 outcomes 5 studies in 50 results : FDA 10 Generic
  3. Immunoglobulin M (IgM) : 2 outcomes 2 studies in 25 results : IBA
  4. Vaccines : 2 outcomes in 3 results : IBA
  5. Clofazimine (Lamprene) : 1 outcome 6 studies in 48 results : FDA 1
  6. Immunoglobulin G (IgG) : 1 outcome 4 studies in 34 results : IBA
  7. Antibodies : 1 outcome 3 studies in 56 results : IBA
  8. Levamisole (Decaris) : 1 outcome 3 studies in 8 results : FDA 1
  9. Immunoglobulins (Immunoglobulin) : 1 outcome 2 studies in 18 results : IBA
  10. Interleukin-2 (IL2) : 1 outcome 1 study in 29 results : IBA
Show All >>

Diseases Related to Lepromatous Leprosy

  1. Leprosy (Hansen's Disease)
  2. Erythema Nodosum
  3. Infection
  4. Tuberculosis
  5. Hypersensitivity (Allergy)
Show All >>

Key Therapies for Lepromatous Leprosy

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 1 outcome 3 studies in 28 results
  2. Immunotherapy : 1 outcome 3 studies in 11 results
  3. Aftercare (After-Treatment) : 1 outcome in 4 results
  4. Transplants (Transplant) : 1 outcome in 3 results
  5. Lasers (Laser) : 1 study in 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.